POZEN Inc.

POZEN Inc.

POZN
POZEN Inc.US flagNASDAQ
5.94
USD
-0.41
- -
POZEN Inc.
POZN
(NASDAQ)

Recent

price

5.94

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
POZEN Inc. was a pharmaceutical firm focused on developing unique therapeutic solutions for underserved medical conditions. Its pipeline primarily included advanced treatments for migraine and explored other areas within pain management. The company pursued a model of advancing drug candidates through clinical stages for out-licensing, ultimately merging to form Aralez Pharmaceuticals plc in 2016.